DavidsTea continues to make progress with the shift towards its e-commerce and wholesale channels growing by 130% y-o-y in 2020. Substantially leaner organization as a result of the transformation and restructuring process should target sales significantly north of C$100 million at an EBITDA margin of 10-15%.
Van we forgot about Funko- One of the biggest upcoming drivers for Funko that could unleash fresh growth is its entry into the NFT market. NFTs, or non-fungible tokens, represent unique ownership of certain pieces of data. NFTs made a rather sudden splash onto the mainstream last year, when buyers started collecting things such as Tweets. Pop culture is a natural intersection of the NFT space, and few companies are as positioned or knowledgable about pop culture than Funko to take full advantage of it. In April, Funko bought a controlling stake in an NFT producer called TokenWave,<-------!! which has created over 10 million NFTs and has 100k app/site visits daily (as of the press release announcing the deal back in April; the traffic figures are likely higher now). Funko expects to launch its initial NFT offerings in June, featuring a unique property each week at a starting price point of $9.99. Products will be sold on the WAX platform, the leading decentralized wallet on the blockchain, which provides verifiable authenticity for purchases of Funko NFTs."
Funko also made tremendous headway on profitability in Q1. The company drove a 100bps increase in gross margin to 41.4%, with the boost in direct channel sales mixes plus a more favorable product mix offsetting rises in freight and logistics costs. And the fact that the company held overhead expenses relatively flat (selling, general, and administrative expenses rose only 8% y/y to support 38% y/y growth in revenue) meant that the company achieved plenty of adjusted EBITDA leverage. As shown in the table below, Funko's adjusted EBITDA in Q1 nearly tripled to $29.8 million, representing a 15.7% adjusted EBITDA margin - up790bpsfrom 7.8% in the year-ago quarter. Figure 4. Funko adjusted EBITDA trends
SPI gains on subsidiary Phoenix Motorcars launching full range of EV charging solutions for the U.S. market Jun. 16, 2021 6:15 AM ETSPI Energy Co., Ltd. (SPI) Phoenix Motorcars, a wholly owned subsidiary of SPI Energy(NASDAQ:SPI)haslauncheda full range of EV charging products forthe U.S. market. The powerful, compact, all-in-one EV charging solutions come in a variety of configurations to serve both residential and commercial customer needs, with 24/7 network support, two-year warranties, and extended warranty options.
Vroom upsizes and prices $550M in convertible senior notes offering Vroom(NASDAQ:VRM)priced its $550M (compared toearlier announced $500M) offering of principal amount of 0.750% convertible senior notes due 2026 in a private offering. The issuance and sale of the notes are scheduled to settle on June 18. Initial purchasers granted 13 days option to purchase up to an additional $75M principal amount of notes. Interest will accrue interest at 0.750% annually, payable semi-annually in arrears; commencing on January 1, 2022. Notes will mature on July 1, 2026. The notes will be redeemable, in whole or in part for cash at company's option on or after July 6, 2024 and on or before the 40th scheduled trading day immediately before the maturity date. Offer net proceeds will be ~$535.7M which are intended to be used for general corporate purposes, including advertising and marketing, expansion of its proprietary logistics operations, increased resources in its customer experience team, technology development, working capital, operating expenses and capital expenditures. Very low interest! %
David stubs his tea- DTEA DAVIDsTEA Inc. 5.31 -0.12(-2.21%) 4:00 PM 06/15/21 Pre-Market:$4.92-0.39(-7.35%)<---------7:07 AM
uniQure enrolls first two patients in second cohort phase I/II trial of AMT-130 07:18 QURE uniQure N.V. announced that the first two patient procedures have been completed in the higher dose, second cohort of the Phase I/II clinical trial of AMT-130 for the treatment of Huntington's disease. The initiation of patient enrollment in this 16-patient cohort follows a meeting last month of the trial's independent Data Safety Monitoring Board that reviewed safety data for the fully enrolled first cohort of ten patients. The Phase I/II study is a double-blind, randomized clinical trial being conducted in the United States. eBay volume appears to be tracking in-line, says Baird 06:45 EBAY Evoqua Water price target raised to $38 from $34 at RBC Capital 06:36 AQUA, XYL RBC Capital Cathie Wood's ARK Investment bought 142K shares of Blade Air Mobility on Tuesday 06:17 BLDE Aclaris Therapeutics price target raised to $50 from $40 at H.C. Wainwright 06:13 ACRS H.C. Wainwright analyst… ACRS-$17.75<------
AppHarvest initiated with an Overweight at Barclays 05:54 APPH Barclays- This guy feels like a dangerous leader--
MOST INNOVATIVE COMPANIES Berkeley Lights Founded in 2011, this East Bay company makes enabling technology for research and drug development. Its flagship Beacon platform uses optofluidics and a unique light-based technology to automate the work of cloning, culturing, and sorting specific cells from biological samples, drastically cutting the time and human labor needed to develop cell lines, discover and engineer antibodies, and do gene editing. Top pharma and biotech companies, including Pfizer, Novartis, Sanofi, Shire, and Teva Pharmaceuticals, are early adopters. In 2018, the company launched a joint venture with the MD Anderson Cancer Center called Optera Therapeutics, which will focus on developing scalable cell-based therapies for cancer.